← Leaderboards
Michael J Otto
Pharmasset, Inc.
$289,584
Attributed
$289,584
Total exposure
2
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$289,584 · 2
By mechanism
R43$289,584 · 2
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Peptides”
- David M Nathan · Massachusetts Institute Of Technology$118,672,444
- John M Lachin · George Washington University$118,672,444
- David Heimbrook · Leidos Biomedical Research, Inc.$91,429,616
- Michael W Weiner · Northern California Institute Res &Educ$78,425,041
- Paul S. Aisen · Cognition Therapeutics, Inc.$69,846,203
- Rolf Apweiler · European Molecular Biology Laboratory$56,677,991
Research focus
PeptidesStaphylococcus EpidermidisBacteria Infection MechanismInflammationNorthern BlottingsBacterial GeneticsCatheterizationAcetylationNosocomial InfectionsWestern BlottingsVirulenceLaboratory RatAntiviral AgentsBacterial ResistanceLaboratory RabbitMolecularHigh Performance Liquid ChromatographyGene Expression ProfilingCell Cell InteractionGenus StaphylococcusHepatitis BHepatitis B Virus GroupHost DefenseBiofilm
Grant awards (9)
Molecular mechanisms of immune evasion in Staphylococcus aureus$901,053
Z01 · FY2008 · AI · contact PI
Molecular mechanisms of pathogenesis in staphylococci$1,597,145
Z01 · FY2007 · AI · contact PI
Molecular mechanisms of pathogenesis in staphylococci$0
Z01 · FY2006 · AI · contact PI
Staphylococcus Epidermidis Biofilm Formation$0
Z01 · FY2005 · AI
Staphylococcus Epidermidis Biofilm Formation$0
Z01 · FY2004 · AI
Staphylococcus Epidermidis Biofilm Formation$0
Z01 · FY2003 · AI
Staphylococcus Epidermidis Biofilm Formation$0
Z01 · FY2002 · AI
Antivirals against HBV$147,584
R43 · FY2001 · AI
RACIVIR FOR TREATMENT OF HEPATITIS B AND HIV INFECTIONS$142,000
R43 · FY2000 · AI